AKT1 and neoplasm: Akt genetic aberrations increasing its activity have been detected in multiple malignancies but are rare events in prostate cancer (≤0.9%), whereas high-level gene amplification of Akt isoforms is more common (up to 4.5%) and positively correlates with the tumour aggressiveness [18].